Soy isoflavone intake is associated with risk of Kawasaki disease

Michael A Portman1, Sandi L Navarro2, Margaret E Bruce3

  • 1Division of Cardiology, Department of Pediatrics, University of Washington, Seattle, WA, USA; Center for Developmental Therapeutics, Seattle Children's Research Institute, Seattle, WA, USA.

Insights

Childhood dietary soy isoflavone intake, particularly genistein, is linked to increased Kawasaki disease (KD) risk in US children. This finding may explain ethnic variations in KD incidence, but maternal intake during pregnancy did not show a significant association.

Area of Science:

  • Pediatric Rheumatology
  • Nutritional Epidemiology
  • Environmental Health

Background:

  • Kawasaki disease (KD) is an acute childhood vasculitis with highest incidence in Asian populations.
  • Ethnic variations in KD incidence suggest potential roles for genetic, dietary, or environmental factors.
  • Soy isoflavones are bioactive compounds found in soy products, with potential health implications.

Purpose of the Study:

  • To investigate the association between dietary soy and isoflavone consumption in children with KD.
  • To examine maternal soy and isoflavone intake during pregnancy and nursing in relation to KD risk.
  • To explore if soy isoflavone consumption explains ethnic-cultural variations in KD incidence in the US.

Main Methods:

  • A case-control study involving nearly 200 US children diagnosed with KD and 200 age-matched controls.
  • Food frequency questionnaires were used to assess dietary soy food intake and isoflavone consumption in children and their mothers.
  • Logistic regression models were employed to analyze the association between isoflavone intake and KD risk, stratified by ethnicity.

Main Results:

  • Childhood consumption of total isoflavones (OR, 2.33) and genistein (OR, 2.46) was significantly associated with increased KD risk.
  • Maternal isoflavone intake during pregnancy and nursing did not show a significant association with KD risk in offspring.
  • Asian-American children with the highest soy isoflavone consumption exhibited a substantially elevated KD risk compared to white children.

Conclusions:

  • Childhood dietary intake of soy isoflavones, especially genistein, is a significant risk factor for Kawasaki disease in a diverse US population.
  • Maternal soy intake during critical periods of gestation and lactation is not associated with KD risk.
  • Dietary isoflavone consumption may contribute to the observed ethnic and cultural disparities in Kawasaki disease incidence.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.6K
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
111
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.2K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.5K
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
442